- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/11 - Oxytocins; Vasopressins; Related peptides
Patent holdings for IPC class A61K 38/11
Total number of patents in this class: 191
10-year publication summary
|
27
|
40
|
40
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 714 |
22 |
| PH Health Limited | 139 |
15 |
| Mondobiotech Laboratories AG | 311 |
7 |
| Trigemina, Inc. | 9 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6509 |
5 |
| Transdermal Biotechnology, Inc. | 76 |
5 |
| The Regents of the University of California | 20230 |
4 |
| Universite D'aix-marseille | 901 |
4 |
| Acerus Pharmaceuticals USA, LLC | 13 |
4 |
| Allergan, Inc. | 2315 |
3 |
| CHU de Toulouse | 11 |
3 |
| Dilafor AB | 19 |
3 |
| Ferring International Center S.A. | 37 |
3 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
3 |
| Pep-Tonic Medical AB | 12 |
3 |
| Oxytone Bioscience B.V. | 4 |
3 |
| AC Pharmaceuticals Co., Ltd. | 22 |
3 |
| Centre hospitalier universitaire de Brest | 5 |
2 |
| Cephalon, Inc. | 115 |
2 |
| Other owners | 88 |